Open AccessFactors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized Dosing
Author(s) -
Jesper Sundell,
Marie Wijk,
Emile Bienvenu,
Angela Äbelö,
KurtJürgen Hoffmann,
Michael Ashton
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00046-21
Subject(s) - pyrazinamide , pharmacokinetics , pharmacology , dosing , medicine , volume of distribution , therapeutic drug monitoring , tuberculosis , isoniazid , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom